Clarissa Brincat

All articles by Clarissa Brincat

• Study identifies the most common G-tube problems

  A recent study examined problems related to gastrostomy tubes (G-tubes), a type of feeding tube used by many patients with TK2d.

• New framework to diagnose and treat mitochondrial diseases

  A recent study provides a better way to understand and classify primary mitochondrial disorders, such as thymidine kinase 2 deficiency (TK2d).

• Global study aims to improve research on mitochondrial disease

  mitoSHARE is working to improve research on mitochondrial disease by collecting real-life health information from patients around the world.

• Progress in testing and treatment brings hope for muscle diseases like TK2d

  New genetic tests and targeted treatments are improving diagnosis and care for muscle diseases like thymidine kinase 2 deficiency (TK2d).

• Mitochondrial diseases may be linked to sleep disorders

  Patients with a mitochondrial disease called MELAS syndrome were found to have a high rate of obstructive sleep apnea and poor sleep quality.

• First treatment for TK2d may soon be approved in Europe

  The European Medicines Agency (EMA) has recommended approving Kygevvi (doxecitine and doxribtimine) for use in the European Union.

• Study: Patients treated with Kygevvi saw a reduced risk of death

  Patients who received a newly-approved drug for TK2d had much lower rates of death than patients who were not.